IP Library Granted Patent US 8,221,485
Granted Patent B2
US 8,221,485 · App. 12/398,406 · Granted Jul 17, 2012

Catheter and system for introducing an intraluminal endoprosthesis

Assignee: Biotronik VI Patent AG
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,221,485
App. No.
12/398,406
Granted
Jul 17, 2012
Kind
B2
Abstract

A catheter ( 10 ) having an internal tube ( 13 ) and an external tube ( 14 ) which at least sectionally encloses the internal tube ( 13 ). The external tube ( 14 ) is connected to a balloon ( 16 ) having an endoprosthesis section ( 18 ) which positions an intraluminal endoprosthesis ( 20 ). The catheter ( 10 ) has stiffening means ( 31, 33, 34, 35 ) located in the area of at least one end of the endoprosthesis section ( 18 ) in its longitudinal direction on the internal tube ( 13 ). Also disclosed is a system comprising an intraluminal endoprosthesis ( 20 ) and a catheter ( 10 ) used for introducing an intraluminal endoprosthesis ( 20 ), preferably a stent, into a body cavity.

Claims (23)

1. A catheter, comprising:

a) an internal tube;

b) an external tube which at least sectionally encloses the internal tube;

c) a balloon having an endoprosthesis section having a proximal end and a distal end which can position an intraluminal endoprosthesis, the balloon being connected to the external tube; and

d) a first set of metal rings positioned proximate to the endoprosthesis proximal end and a second set of metal rings positioned proximate to the endoprosthesis distal end, the first and second sets of rings crimped onto the internal tube, at least two rings in each set having different lengths from each other, the first and second sets of rings being provided at predetermined spacings so as to provide a rigidity transition at the proximal and distal ends, respectively, of the endoprosthesis section.

2. The catheter of claim 1 , wherein the first and second sets of metal rings are made of one or more metals from the group consisting of platinum and iridium.

3. The catheter of claim 1 , wherein the number of metal rings in each set of rings is from 2 to 5, the rings having either a length of approximately from 0.1 mm to 1 mm or a spacing of approximately from 0.1 mm to 1 mm, or both.

4. The catheter of claim 1 wherein the metal rings are made of a material visible upon x-ray irradiation.

5. The catheter of claim 1 wherein there are at least three rings in the first set or the second set or both, and wherein a distance between the first ring and the second ring is different from a distance between the second ring and the third ring.

6. A system for introducing an intraluminal endoprosthesis, preferably a stent, into a body cavity, comprising:

a) an intraluminal endoprosthesis, and

b) a catheter comprising:

i) an internal tube;

ii) an external tube which at least sectionally encloses the internal tube;

iii) a balloon having an endoprosthesis section which can position an intraluminal endoprosthesis, the balloon being connected to the external tube; and

iv) a first set of metal rings positioned proximate to the endoprosthesis proximal end and a second set of metal rings positioned proximate to the endoprosthesis distal end, the first and second sets of rings crimped onto the internal tube, at least two rings in each set having different lengths from each other, the first and second sets of rings being provided at predetermined spacings so as to provide a rigidity transition at the proximal and distal ends, respectively, of the endoprosthesis section,

wherein the intraluminal endoprosthesis is located in the endoprosthesis section on the balloon, the endoprosthesis being crimped externally onto the endoprosthesis section of the balloon.

7. The system of claim 6 , wherein the endoprosthesis further comprises an x-ray marker disposed on at least one of the ends of the endoprosthesis in the longitudinal direction.

8. The system of claim 6 , wherein the endoprosthesis further comprises a pharmaceutically active substance.

9. The system of claim 6 , wherein the first and second sets of metal rings are made of one or more metals from the group consisting of platinum and iridium.

10. The system of claim 6 , wherein the number of metal rings in each set of rings is from 2 to 5, the rings having either a length of approximately from 0.1 mm to 1 mm or a spacing of approximately from 0.1 mm to 1 mm, or both.

11. The system of claim 6 , wherein the endoprosthesis comprises a degradable material.

12. The system of claim 6 wherein the metal rings are made of a material visible upon x-ray irradiation.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 25, 2018
From: BIOTRONIK VI PATENT AG
To: BIOTRONIK AG
Reel/Frame 047166/0462 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 9, 2009
From: SURBER, BETTINA; NEF, THOMAS
To: BIOTRONIK VI PATENT AG
Reel/Frame 022361/0861 →
Priority Claims (1)
DE 10 2008 012 744 · Mar 5, 2008 · national
Continuity (1)
Related Publication 20090228091A1 · Sep 10, 2009